1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Biliary Stents Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
        4.3.4. Global Biliary Stents Market Analysis and Forecast, 2017–2031
5. Key Insights
    5.1. Key Product/Brand Analysis
    5.2. Technological Advancement
    5.3. COVID-19 Impact Analysis
6. Global Biliary Stents Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Metal
        6.3.2. Polymer
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Biliary Stents Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Malignant Biliary Obstruction
        7.3.2. Benign Biliary Strictures
        7.3.3. Biliary Leak
        7.3.4. Others
    7.4. Market Attractiveness Analysis, by Application
8. Global Biliary Stents Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals/Clinics
        8.3.2. Ambulatory Services
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Biliary Stents Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Biliary Stents Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Metal
        10.2.2. Polymer
    10.3. Market Value Forecast, by Application, 2017–2031
        10.3.1. Malignant Biliary Obstruction
        10.3.2. Benign Biliary Strictures
        10.3.3. Biliary Leak
        10.3.4. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals/Clinics
        10.4.2. Ambulatory Services
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Biliary Stents Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Metal
        11.2.2. Polymer
    11.3. Market Value Forecast, by Application, 2017–2031
        11.3.1. Malignant Biliary Obstruction
        11.3.2. Benign Biliary Strictures
        11.3.3. Biliary Leak
        11.3.4. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals/Clinics
        11.4.2. Ambulatory Services
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Biliary Stents Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Metal
        12.2.2. Polymer
    12.3. Market Value Forecast, by Application, 2017–2031
        12.3.1. Malignant Biliary Obstruction
        12.3.2. Benign Biliary Strictures
        12.3.3. Biliary Leak
        12.3.4. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals/Clinics
        12.4.2. Ambulatory Services
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Biliary Stents Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Metal
        13.2.2. Polymer
    13.3. Market Value Forecast, by Application, 2017–2031
        13.3.1. Malignant Biliary Obstruction
        13.3.2. Benign Biliary Strictures
        13.3.3. Biliary Leak
        13.3.4. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals/Clinics
        13.4.2. Ambulatory Services
        13.4.3. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Biliary Stents Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Metal
        14.2.2. Polymer
    14.3. Market Value Forecast, by Application, 2017–2031
        14.3.1. Malignant Biliary Obstruction
        14.3.2. Benign Biliary Strictures
        14.3.3. Biliary Leak
        14.3.4. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals/Clinics
        14.4.2. Ambulatory Services
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product Type
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Global Biliary Stents Market, Company Share Analysis (2022)
    15.2. Company Profiles
        15.2.1. Boston Scientific Corporation
            15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.1.2. Product Portfolio
            15.2.1.3. Financial Overview
            15.2.1.4. SWOT Analysis
            15.2.1.5. Strategic Overview
        15.2.2. Cook Medical
            15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.2.2. Product Portfolio
            15.2.2.3. Financial Overview
            15.2.2.4. SWOT Analysis
            15.2.2.5. Strategic Overview
        15.2.3. Olympus Corporation
            15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.3.2. Product Portfolio
            15.2.3.3. Financial Overview
            15.2.3.4. SWOT Analysis
            15.2.3.5. Strategic Overview
        15.2.4. Medtronic
            15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.4.2. Product Portfolio
            15.2.4.3. Financial Overview
            15.2.4.4. SWOT Analysis
            15.2.4.5. Strategic Overview
        15.2.5. C.R. Bard (Becton, Dickinson & Company)
            15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.5.2. Product Portfolio
            15.2.5.3. Financial Overview
            15.2.5.4. SWOT Analysis
            15.2.5.5. Strategic Overview
        15.2.6. CONMED Corporation
            15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.6.2. Product Portfolio
            15.2.6.3. Financial Overview
            15.2.6.4. SWOT Analysis
            15.2.6.5. Strategic Overview
        15.2.7. Merit Medical Systems, Inc.
            15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.7.2. Product Portfolio
            15.2.7.3. Financial Overview
            15.2.7.4. SWOT Analysis
            15.2.7.5. Strategic Overview
        15.2.8. Cordis Corporation (Cardinal Health)
            15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.8.2. Product Portfolio
            15.2.8.3. Financial Overview
            15.2.8.4. SWOT Analysis
            15.2.8.5. Strategic Overview
        15.2.9. ENDO-FLEX GmbH
            15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            15.2.9.2. Product Portfolio
            15.2.9.3. Financial Overview
            15.2.9.4. SWOT Analysis
            15.2.9.5. Strategic Overview
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			